Idiopathic anaphylaxis and systemic mastocytosis Ivo M. B. FrancischettiIrina Maric Images in Hematology 12 October 2019 Pages: 643 - 644
Promyelocyte-like blasts in B-lymphoblastic leukemia of a 67-year-old male patient Yu MaQing LengEndi Wang Images in Hematology 25 September 2019 Pages: 645 - 646
A megakaryocyte in a peripheral blood smear Tokiko NakaiYasuyuki Okamoto Images in Hematology 05 October 2019 Pages: 647 - 647
Evaluation of a biosimilar granulocyte colony-stimulating factor for peripheral blood stem cell mobilization in Japanese healthy donors: a prospective study Keijiro SatoKen IshiyamaShinji Nakao Original Article 21 September 2019 Pages: 648 - 653
Safety and pharmacokinetics of quizartinib in Japanese patients with relapsed or refractory acute myeloid leukemia in a phase 1 study Kensuke UsukiHiroshi HandaSakura Sakajiri Original Article 29 July 2019 Pages: 654 - 664
Efficacy and safety of quizartinib in Japanese patients with FLT3-ITD positive relapsed or refractory acute myeloid leukemia in an open-label, phase 2 study Takeshi TakahashiKensuke UsukiSakura Sakajiri Original Article 31 August 2019 Pages: 665 - 674
Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt) Koji NagafujiItaru MatsumuraYuzuru Kanakura Original Article 19 September 2019 Pages: 675 - 682
Effect of study-level factors on treatment-free remission rate in patients with chronic myeloid leukemia: a systematic review and meta-analysis Jinchul KimJisun ParkJinhyun Cho Original Article 27 September 2019 Pages: 683 - 689
TERT and JAK2 polymorphisms define genetic predisposition to myeloproliferative neoplasms in Japanese patients Masafumi MatsugumaToshiaki YujiriYukio Tanizawa Original Article 30 September 2019 Pages: 690 - 698
Novel lysyl oxidase inhibitors attenuate hallmarks of primary myelofibrosis in mice Orly LeivaSeng Kah NgKatya Ravid Original Article 21 October 2019 Pages: 699 - 708
Inotuzumab ozogamicin versus standard of care in Asian patients with relapsed/refractory acute lymphoblastic leukemia Naohito FujishimaToshiki UchidaMasayuki Hino Original Article 13 November 2019 Pages: 709 - 722
Successful outcome with reduced-intensity condition regimen followed by allogeneic hematopoietic stem cell transplantation for relapsed or refractory anaplastic large-cell lymphoma Reiji FukanoTetsuya MoriKen Tabuchi Original Article 16 October 2019 Pages: 723 - 728
Successful granulocyte apheresis using medium molecular weight hydroxyethyl starch Mai NanyaKimiko YurugiHideyo Hirai Original Article 10 October 2019 Pages: 729 - 735
Phase I study of graft-versus-host disease prophylaxis including bortezomib for allogeneic hematopoietic cell transplantation from unrelated donors with one or two HLA loci mismatches in Japanese patients Takahiko NakaneHiroshi OkamuraHirohisa Nakamae Original Article 27 September 2019 Pages: 736 - 742
Supportive care for hemostatic complications associated with pediatric leukemia: a national survey in Japan Shinya OsoneKeitaro FukushimaSouichi Adachi Original Article 26 September 2019 Pages: 743 - 750
Cryoglobulinemic vasculitis with interruption of ibrutinib therapy for chronic lymphocytic leukemia (CLL) Nicholas WrightEnsi VoshtinaJoshua Field Case Report 07 September 2019 Pages: 751 - 755
Successful treatment with 2-chlorodeoxyadenosine of refractory pediatric Langerhans cell histiocytosis with initial involvement of the gastrointestinal tract Azusa MayumiToshihiko ImamuraHajime Hosoi Case Report 26 July 2019 Pages: 756 - 762
